PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
17-Oct-2023 Cartherics appoints new Chief Scientific Officer Cartherics
17-Oct-2023 Huateng Pharma Launches Exciting New Product Line - Fexuprazan and Vonoprazan Intermediates Hunan Huateng Pharmaceutical Co., Ltd
16-Oct-2023 ‘Strategic alliances’ in pharma and biotech: innovation through cooperation Bachem
16-Oct-2023 Navin Fluorine International Ltd. launches Navin Molecular: The new brand for its future-thinking CDMO business Navin Molecular
13-Oct-2023 Phase 3 Data Analysis Presented at EADV 2023 Showed Bimekizumab Achieved High Thresholds of Clinical Response in Hidradenitis Suppurativa UCB
12-Oct-2023 Dr. Yooni Kim, Vice President of Clinical Services at Novotech, Delivers Keynote Address at Veeva Korea Summit Novotech
12-Oct-2023 BIOCAPTIVA to conduct ex-vivo study to evaluate the potential of the BioCaptis device to capture cell free DNA to improve pleural disease diagnosis BIOCAPTIVA
12-Oct-2023 CD Bioparticles Launches 3D Cell Culture Substrate for Bio-research CD Bioparticles
12-Oct-2023 STEMart Announces Rapid Endotoxin Testing Services for Medical Devices STEMart
11-Oct-2023 OMass Therapeutics Announces its Attendance at Upcoming Conferences and Events OMass Therapeutics
10-Oct-2023 Valo Therapeutics Announces Acquisition of Bruker Corporation’s Latest Mass Spectrometer Platform for Tumor Antigen Identification with ValoTx’s PeptiCHIP Technology Valo Therapeutics
10-Oct-2023 GPCR Therapeutics Expands Pipeline into Fibrosis with a Combination Approach Targeting LPA1 GPCR Therapeutics
10-Oct-2023 Mission Therapeutics to Present at Michael J. Fox Foundation’s 15th Annual Parkinson’s Disease Therapeutics Conference Mission Therapeutics
10-Oct-2023 Neoadjuvant study with LTX-315 in early-stage melanoma patients to be presented at the 15th Nordic melanoma meeting Lytix Biopharma
10-Oct-2023 Ori Biotech to Present Scientific Data at 2023 Cell & Gene Meeting on the Mesa Ori Biotech
10-Oct-2023 Bulletin from Moberg Pharma´s Extraordinary General Meeting Moberg Pharma
10-Oct-2023 Innovative Trials launches ‘first of its kind’ service to boost clinical trial patient recruitment and retention Innovative Trials
10-Oct-2023 Life sciences leaders unite to condemn radical plans to rewrite medicines scheme British Pharmaceutical Industry (ABPI)
10-Oct-2023 AstronauTx closes £48 million ($61 million) Series A financing to create new treatments for Alzheimer’s disease AstronauTx Ltd
10-Oct-2023 Brandon Capital Joins AstronauTx’ £48 million ($61 million) Series A Financing to Create New Treatments for Alzheimer’s disease Brandon Capital